Eavesdropping on conversations between cells Martin Harris Newsletter Article 15 February 2013 Pages: 3 - 4
Another option for refractory idiopathic thrombocytopenic purpura Newsletter Article 15 February 2013 Pages: 5 - 5
Resource utilisation and costs in migraine sufferers Newsletter Article 15 February 2013 Pages: 8 - 8
Pilot trial of recombinant hirudin in deep vein thrombosis Newsletter Article 15 February 2013 Pages: 8 - 8
‘Protective’ apoE isoforms provide new lead in Alzheimer’s therapy Theresa Szeto Newsletter Article 15 February 2013 Pages: 9 - 9
Breast cancer tumours primed by arginine supplements? Newsletter Article 15 February 2013 Pages: 10 - 10
Neridronic acid is effective in treating malignant hypercalcaemia Newsletter Article 15 February 2013 Pages: 11 - 11
Lamotrigine shows promise in children with drug-resistant epilepsy Newsletter Article 15 February 2013 Pages: 12 - 12
Cladribine salvage therapy active in indolent non-Hodgkin’s lymphoma Newsletter Article 15 February 2013 Pages: 12 - 12
Venlafaxine matches imipramine in major depression Newsletter Article 15 February 2013 Pages: 12 - 12
IL-2, fluourouracil & interferon-α double response rate in renal cancer Jill Stein Newsletter Article 15 February 2013 Pages: 13 - 13
Better survival with high-dose aciclovir in advanced HIV infection Newsletter Article 15 February 2013 Pages: 14 - 14
Dihydrotachysterol vs calcitriol in renal osteodystrophy Newsletter Article 15 February 2013 Pages: 14 - 14
Provision of direct care by pharmacists to patients receiving clozapine Newsletter Article 15 February 2013 Pages: 17 - 17
Anti-GAD is predictive of IDDM before onset of clinical symptoms Newsletter Article 15 February 2013 Pages: 17 - 17
Concomitant didanosine alters zidovudine pharmacokinetics Newsletter Article 15 February 2013 Pages: 19 - 19
Possible reason for increased sudden death in CAST Newsletter Article 15 February 2013 Pages: 20 - 20
Clinicians, be aware of anticoagulant interactions Newsletter Article 15 February 2013 Pages: 21 - 21
Growth of antivirals, vaccines and interferons in Europe Newsletter Article 15 February 2013 Pages: 22 - 22